HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

5th Edition of

International Public Health Conference

March 19-21, 2026 | Singapore

Cancer screening

Cancer screening

Cancer screening is an integral component of preventive medicine, aiming to detect malignancies at an early, more treatable stage before symptoms manifest. These screenings involve systematic examinations or tests to identify cancer or precancerous conditions in individuals who may not yet show any signs of the disease. Common cancer screening methods include mammography for breast cancer, Pap smears for cervical cancer, colonoscopies for colorectal cancer, and prostate-specific antigen (PSA) tests for prostate cancer. The goal is to catch abnormalities before they progress, allowing for timely intervention and increased chances of successful treatment. While screening recommendations may vary based on age, gender, and risk factors, the overarching objective is to facilitate early detection, which is a cornerstone of preventive medicine. Regular screenings, coupled with a comprehensive understanding of personal risk factors, empower individuals and healthcare providers to collaborate effectively in managing and mitigating the impact of cancer, aligning with the broader goal of promoting health and well-being through preventive measures.

Committee Members
Speaker at International Public Health Conference 2026 - David John Wortley

David John Wortley

International Society of Digital Medicine (ISDM), United Kingdom
Speaker at International Public Health Conference 2026 - Bob Esquerre

Bob Esquerre

Esquerre Fitness Group International, United States
Speaker at International Public Health Conference 2026 - Sergey Suchkov

Sergey Suchkov

National Center for Human Photosynthesis, Mexico

Submit your abstract Today

Watsapp